dual IL 17 A & F nanobody typical response at 12 wks not significantly better - how many IL17 inhibs do we need? @RheumNow #EULAR2024 https://t.co/50dIKyO0e4
13-06-2024
By downloading this material, I acknowledge that it may be used only for personal use and personal education and that I will accredit RheumNow.com as the source and owner of this material. Commercial use or mass reproduction of this material without permission from RheumNow (info@rheumnow.com) is prohibited.
